From: Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo
Inflammation
Degeneration
Hepatocyte necrosis
Fibrosis
Control
−
MFD alone
CCl4 alone
+++
++
CCl4 + MFD (0.1 mg/kg)
CCl4 + MFD (0.5 mg/kg)
+